Volgabus to test driverless buses at new R&D centre at Skolkovo730
Medvedev: ‘Skolkovo is a fully-fledged city’545
Class of 2016: Skoltech celebrates its second graduation ceremony502
Skolkovo project Surfancy wins MEGA accelerator programme499
EdTech website Dnevnik.ru wins at EdTechXEurope conference410
BRICS intellectual property tsars swap expertise at Skolkovo407
Beyond beauty: industrial design festival aims to give Russian startups a commercial makeover383
From the lab to the market: Dutch, Russian innovators talk commercialisation347
Space startup calls on IT whizzes to devise app for monitoring Russia’s deadly forest fires340
‘There’s tons of money in China:’ Chinese investors, tech entrepreneurs pay visit to Skolkovo338
Skolkovo project Surfancy wins MEGA accelerator programme0
Volgabus to test driverless buses at new R&D centre at Skolkovo0
Medvedev: ‘Skolkovo is a fully-fledged city’0
BRICS intellectual property tsars swap expertise at Skolkovo0
Class of 2016: Skoltech celebrates its second graduation ceremony0
Space startup calls on IT whizzes to devise app for monitoring Russia’s deadly forest fires0
EdTech website Dnevnik.ru wins at EdTechXEurope conference0
‘There’s tons of money in China:’ Chinese investors, tech entrepreneurs pay visit to Skolkovo0
Beyond beauty: industrial design festival aims to give Russian startups a commercial makeover0
From the lab to the market: Dutch, Russian innovators talk commercialisation0
Skolkovo biomed cluster resident 3D Bioprinting Solutions has announced the successful printing of a mouse’s thyroid gland.
3D Bioprinting Solutions unveiled Russia's first bioprinter in October. Photo: 3D Bioprinting Solutions
If confirmed, it would reportedly be the world’s first synthetic construction of a complete, transplantable living organ.
“This is undoubtedly a breakthrough in the world of regenerative medicine,” said the bioprinter’s developer Vladimir Mironov. “We have successfully demonstrated the possibilities of Russia’s first bioprinter, and we’re continuing our validation work, systematically testing and optimizing our technology for 3D organ bioprinting,” he added.
The coming weeks will see Mironov’s team attempt to transplant the organ – a matter of millimeters thick - into a mouse suffering from hyperthyroidism, the results of which will be announced at the International Bioprinting Congress in Singapore in June.
The company selected the mouse’s thyroid gland because it is relatively small and simple in design, the lab said. In transplantation, the chance of rejection is minimized by the fact that the mouse’s own stem cells were used as the foundations for the organ, the lab said.
A proud website statement simply read: “The 3D Biprinting Solutions laboratory has successfully conducted the bioprinting of an organ construct of the thyroid gland of a mouse.”
“As was promised last fall, the lab’s scientists finished their work on time – by March 15,” the statement said.
A bioprinter is a machine that fabricates living cells, a technology that could revolutionize modern medicine by providing everything from skin grafts to replacement organs.
The firm 3D Bioprinting Solutions unveiled its 3D bioprinter to the public at the Open Innovations forum in the Russian capital October 14-16.
The bioprinter works by distributing so-called tissue spheroids, or bio-ink, in successive layers in a kind of scaffold structure made of hydrogel. The gel is washed away, leaving behind three-dimensional tissue that matches a computer design down to the individual cell.
Commenting on what Mironov’s achievement means for science, Gelena Livshits, a project manager for Skolkovo’s biomed cluster, said printing an entire organ, not simply a strand of tissue as competitors in the West do, would be a “genuine sensation.”